6505--Genzyme Corporation

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC FEDERAL SUPPLY SCHEDULE (36F797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36F79726D0210

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
This procurement notice, titled "6505--Genzyme Corporation," announces an award under the Federal Supply Schedule managed by the National Acquisition Center (NAC) of the Department of Veterans Affairs. The notice is classified as an AWARD_NOTICE, indicating that the contract has been granted and is currently active. The scope of this procurement centers on pharmaceutical preparation manufacturing, as defined by NAICS Code 325412 (2022 version). The associated Product Service Code is 6505, which pertains to drugs and biologicals. The intended outcome of this contract is to ensure the reliable supply of pharmaceutical products manufactured by Genzyme Corporation, supporting the Department of Veterans Affairs in its mission to provide essential medical treatments and therapies to veterans. The contracting entity is the NAC Federal Supply Schedule (organization key: 100173494), a federal office within the Department of Veterans Affairs. The NAC is responsible for managing large-scale procurement activities that facilitate access to medical supplies and pharmaceuticals for VA facilities nationwide. The primary point of contact for this contract is the FSS Help Desk, which can be reached via email at [email protected] or by phone at (708) 786-7737. This award notice is posted on SAM.gov, with the opportunity ID 695e7fadbecb43b6a2a5fe50b845835d. Additional information, including one attachment, is available through the provided notice URL. The procurement is governed by federal acquisition regulations and is part of the ongoing efforts to maintain a robust supply chain for VA healthcare operations. Contractors interested in similar opportunities should note that this procurement is focused on pharmaceutical manufacturing and distribution, with requirements likely centered on quality assurance, regulatory compliance, and timely delivery of products. The notice does not specify any set-aside requirements or special considerations, nor does it detail the specific products or quantities involved. However, the classification codes and contracting entity context suggest a consistent need for high-quality pharmaceutical preparations to support veteran healthcare. Overall, this contract represents a critical component of the VA's supply chain, ensuring that veterans have access to necessary medications and therapies. The NAC Federal Supply Schedule remains a key channel for such procurements, and contractors with capabilities in pharmaceutical manufacturing and distribution may find future opportunities aligned with this scope.